Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
Hisaya Kawate, Ryoichi TakayanagiDepartment of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanAbstract: Bazedoxifene, a novel selective estrogen receptor modulator, has been developed to have favorable effects on bone and the lipid profile w...
Enregistré dans:
| Auteurs principaux: | Kawate H, Takayanagi R |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2011
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/a20acec5398f45c3a04962dcb0ec23be |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Eldecalcitol for the treatment of osteoporosis
par: Noguchi Y, et autres
Publié: (2013) -
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
par: Luigi Gennari, et autres
Publié: (2010) -
Selective estrogen receptor modulators: tissue specificity and clinical utility
par: Martinkovich S, et autres
Publié: (2014) -
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
par: Paula Rackoff
Publié: (2009) -
Alendronate improves QOL of postmenopausal women with osteoporosis
par: Hisaya Kawate, et autres
Publié: (2010)